This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Epidemiology of non alcoholic fatty liver disease (NAFLD)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

epidemiology

With the rapid rise in sedentary life style, metabolic syndrome and obesity, prevalence of NAFLD amongst the general population has increased considerably.

  • worldwide prevalence of NAFLD is thought to be 20% in the general population and up to 70% in patients with type 2 diabetes mellitus (1)
  • the community-based Framingham heart study population has reported a prevalence of 17% (19% in men and 15% in women) with the prevalence approaching 90% in patients considering bariatric surgery (2)
  • NAFLD is the most common cause of chronically elevated LFTs in the United States in both diabetic and nondiabetic individuals
  • with respect to patients with NAFLD, 60-95% are obese, 28-55% have type 2 diabetes, and 20-92% have hyperlipidemia (3)

Prevalence of NAFLD

  • increases with age
  • is higher in men than in women
    • in a study of 26,527 subjects undergoing medical checkups, the prevalence of NAFLD was 31% in men and 16% in women
  • in hispanic individuals is significantly higher and in non-hispanic blacks is significantly lower when compared to non-hispanic whites (4).

Prevalence of NAFLD in High Risk Groups

  • patients with severe obesity undergoing bariatric surgery
    • the prevalence of NAFLD can exceed 90%
    • up to 5% of patients may have unsuspected cirrhosis
  • type 2 diabetes mellitus patients
    • ultrasonographic studies have reported a 69% prevalence of NAFLD in type 2 diabetes patients
  • dyslipidemia
    • the prevalence of NAFLD was estimated to be 50% in patients attending lipid clinics

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.